Dr. Naleway is an epidemiologist whose research focuses on immune-mediated diseases, such as asthma, atopic dermatitis, photodermatitis, and lupus. She is also interested in infectious disease epidemiology. Dr. Naleway is an investigator with the CDC-funded Vaccine Safety Datalink, a national project linking automated medical records data from eight managed care organizations to monitor vaccine safety.

Dr. Naleway received her MS and PhD in Epidemiology from the University of Iowa's College of Public Health, where she served as Research Assistant for the International Study of Unruptured Intracranial Aneurysms, and was a Teaching Assistant for two courses in epidemiological methods. Dr. Naleway completed a post-doctoral fellowship in epidemiology at the Marshfield Clinic Research Foundation, and was an Instructor for the Internal Medical Residency Research Lecture Series at the Marshfield Clinic.

In addition to being a CHR investigator, Dr. Naleway is a Clinical Assistant Professor for the Oregon Health and Science University's Department of Public Health and Preventive Medicine. She also recently served as a member of the CDC/American Academy of Dermatology Smallpox and Atopic Dermatitis Work Group. Dr. Naleway is currently a professional member of the Society for Epidemiologic Research, Lupus Foundation of America, and the Alliance for Lupus Research.

Current Studies:

	Amyotrophic Lateral Sclerosis (ALS) Registry Pilot—ALS Registry
	Determinants of poor response to flu vaccine in the elderly
	Long-Term Oxygen Treatment Trial — Regional Clinical Center- LOTT RCC
	Population-based Surveillance for Influenza and Adverse Events Potentially Associated with Receipt of Medical Countermeasures for Seasonal and Pandemic Influenza Under Activity J—VSD Influenza Act J
	Rapid Surveillance for Influenza-Like Illness – ILI Surveillance
	Vaccine Safety Datalink: Comprehensive Linked Data Collection of Medical Events and Immunization—VSD Adult
	Vaccine Safety Datalink: Comprehensive Linked Data Collection of Medical Events and Immunization—VSD Youth
	Vaccine Safety Datalink:(VSD) Evaluation of HPV Associated Outcomes Under Activity G—VSD HPV Activity G

Recently Completed Studies:

The Incidence of Neonatal Herpes Simplex Virus Infection Using the Vaccine Safety Datalink -CHIMPS HSV

E-mail: Allison.Naleway@kpchr.org